RADICE, SONIA
RADICE, SONIA
DIPARTIMENTO DI SCIENZE CLINICHE "LUIGI SACCO" (attivo dal 01/01/2002 al 27/04/2012)
On the potential of drug repurposing in dysphagia treatment: New insights from a real-world pharmacovigilance study and a systematic review
2023 V. Battini, S. Rocca, G. Guarnieri, A. Bombelli, M. Gringeri, G. Mosini, M. Pozzi, M. Nobile, S. Radice, E. Clementi, A. Schindler, C. Carnovale, N. Pizzorni
The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression
2023 V. Battini, G. Cirnigliaro, R. Leuzzi, E. Rissotto, G. Mosini, B. Benatti, M. Pozzi, M. Nobile, S. Radice, C. Carnovale, B. Dell'Osso, E. Clementi
Two Years of Active Pharmacovigilance Surveillance and Therapeutic Reconciliation in Frail Populations: The MEAP 3.0 Study
2023 A. Bombelli, G. Guarnieri, N. Lombardi, M.G. Sullo, E. Spina, G. Crescioli, C. Rafaniello, G. Cicala, V. Marangon, R. Folchino, S. Vecchio, G. Mosini, S. Radice, E. Clementi
Antibiotic-Induced Neutropenia in Pediatric Patients: New Insights From Pharmacoepidemiological Analyses and a Systematic Review
2022 V. Battini, A. Mari, M. Gringeri, F. Casini, F. Bergamaschi, G. Mosini, G. Guarnieri, M. Pozzi, M. Nobile, G.V. Zuccotti, E. Clementi, S. Radice, V. Fabiano, C. Carnovale
Reply to: correspondence on "Herpes Zoster and Simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis"
2022 M. Gringeri, V. Battini, G. Cammarata, G. Mosini, G. Guarnieri, C. Leoni, M. Pozzi, S. Radice, E. Clementi, C. Carnovale
β-blockers associated hypoglycaemia: new insights from a real-world pharmacovigilance study [Beta-blocker-associated hypoglycaemia: New insights from a real-world pharmacovigilance study]
2021 C. Carnovale, M. Gringeri, V. Battini, G. Mosini, E. Invernizzi, F. Mazhar, F. Bergamaschi, M. Fumagalli, G.V. Zuccotti, E.G.I. Clementi, S. Radice, V. Fabiano
Preliminary evidence on the safety profile of BNT162b2 (Comirnaty): new insights from data analysis in EudraVigilance and adverse reaction reports from an Italian health facility
2021 M. Gringeri, G. Mosini, V. Battini, G. Cammarata, G. Guarnieri, C. Carnovale, E. Clementi, S. Radice
Inflammasome Targeted Therapy in Pregnancy: New Insights From an Analysis of Real-World Data From the FAERS Database and a Systematic Review
2021 C. Carnovale, E. Tombetti, V. Battini, F. Mazhar, S. Radice, M. Nivuori, E. Negro, S. Tamanini, A. Brucato
The impact of anti-TNFα agents on weight-related changes : new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database
2021 F. Mazhar, V. Battini, M. Gringeri, M. Pozzi, G. Mosini, A.M.N. Marran, S. Akram, R.P. van Manen, S. Radice, E. Clementi, C. Carnovale
Drug Use in Pediatric Patients Admitted to Rehabilitation For Severe Acquired Brain Injury : Analysis of the Associations With Rehabilitation Outcomes
2021 M. Pozzi, S. Galbiati, F. Locatelli, C. Carnovale, S. Radice, S. Strazzer, E. Clementi
Hyponatremia Following Antipsychotic Treatment: In Silico Pharmacodynamics Analysis of Spontaneous Reports From the US Food and Drug Administration Adverse Event Reporting System Database and an Updated Systematic Review
2021 F. Mazhar, V. Battini, M. Pozzi, E. Invernizzi, G. Mosini, M. Gringeri, A. Capuano, C. Scavone, S. Radice, E. Clementi, C. Carnovale
Severe hypoglycemia in children treated with nadolol: A case report and FDA adverse event reporting system (FAERS) database analysis
2021 F. Bergamaschi, M. Fumagalli, S. Mannarino, P. Carlucci, S. Radice, M. Gringeri, G. Mosini, C. Carnovale, V. Battini, V. Fabiano
We Really Need Clear Guidelines and Recommendations for Safer and Proper Use of Aripiprazole and Risperidone in a Pediatric Population: Real-World Analysis of EudraVigilance Database
2020 C. Rafaniello, M.G. Sullo, C. Carnovale, M. Pozzi, B. Stelitano, S. Radice, R. Bernardini, F. Rossi, E. Clementi, A. Capuano
Are dizziness-related symptoms signals for suboptimal treatment of hypothyroidism? New insights from the FDA adverse event reporting system (FAERS) database
2020 C. Carnovale, V. Battini, F. Mazhar, G. Mosini, M. Gringeri, A. Vicenzi, E. Clementi, S. Radice
Weight and body mass index increase in children and adolescents exposed to antipsychotic drugs in non-interventional settings : a meta-analysis and meta-regression
2020 M. Pozzi, R.I. Ferrentino, G. Scrinzi, C. Scavone, A. Capuano, S. Radice, M. Nobile, P. Formisano, E. Clementi, C. Bravaccio, C. Carnovale, S. Pisano
Association of Hyponatraemia and Antidepressant Drugs: A Pharmacovigilance-Pharmacodynamic Assessment Through an Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
2019 F. Mazhar, M. Pozzi, M. Gentili, M. Scatigna, E. Clementi, S. Radice, C. Carnovale
Bullous pemphigoid induced by dipeptidyl peptidase-4 (DPP-4) inhibitors: A Pharmacovigilance-Pharmacodynamic/Pharmacokinetic assessment through an analysis of the VigiBase®
2019 C. Carnovale, F. Mazhar, E. Arzenton, U. Moretti, M. Pozzi, G. Mosini, O. Leoni, M. Scatigna, E. Clementi, S. Radice
Central nervous system-active drug abused and overdose in children : a worldwide exploratory study using the WHO pharmacovigilance database
2019 C. Carnovale, F. Mahzar, S. Scibelli, M. Gentili, E. Arzenton, U. Moretti, O. Leoni, M. Pozzi, G.G.A.M. Peeters, E. Clementi, M. Medaglia, S. Radice
Adverse Drug Reactions Related to Mood and Emotion in Pediatric Patients Treated for Attention Deficit/Hyperactivity Disorder: A Comparative Analysis of the US Food and Drug Administration Adverse Event Reporting System Database
2019 M. Pozzi, C. Carnovale, F. Mazhar, G.G.A.M. Peeters, M. Gentili, M. Nobile, S. Radice, E. Clementi
The impact of a successful treatment of HCV on glyco-metabolic control in diabetic patients
2019 C. Carnovale, M. Gentili, C. Magni, F. Mazhar, G. Mosini, E. Clementi, S. Radice